Zoledronic acid sequential to teriparatide may promote greater inhibition of bone resorption than zoledronic acid alone

Zoledronic acid sequential to teriparatide may promote greater inhibition of bone resorption than zoledronic acid alone

Background: Teriparatide (TPTD) should be followed by an antiresorptive to maximize bone mineral density gain and anti-fracture protection. Infrequent zoledronic acid (ZOL) administration has demonstrated effectiveness. The duration of ZOL effect following TPTD is unknown. Objective: To evaluate the...

Full description

Bibliographic Details
Main Authors: Sharon Giveon, Galia Zacay, Iris Vered, A. Joseph Foldes, Liana Tripto-Shkolnik
Format: Article
Language:English
Published: SAGE Publishing 2023-11-01
Series:Therapeutic Advances in Endocrinology and Metabolism
Online Access:https://doi.org/10.1177/20420188231213639

Similar Items

Similar Items